Grandhope Biotech,Dongbao Biotech and Feiliks to land on ChiNext board
2011-7-6

Grandhope Biotech (Stock Code: 300238), Dongbao Biotech (Stock Code: 300239) and Feiliks (Stock Code: 300240) will land on ChiNext board on July 06, 2011.

 

Grandhope Biotech IPO volume is 15.30 million with the post-IPO share capital totaling 61.10 million yuan, the offering price of 18.20 yuan per share, the raised funds expected up to 278 million yuan. Dongbao Biotech IPO volume is 19 million with the post-IPO share capital totaling 75.98 million yuan, the offering price of 9.00 yuan per share, the raised funds expected up to 171 million yuan. Feiliks IPO volume is 27 million with the post-IPO share capital totaling 107 million yuan, the offering price of 20.00 yuan per share, the raised funds expected up to 540 million yuan.

 

Grandhope Biotech Co., Ltd. principally engages in the research, development, production and sale of regeneration medical materials and equipments. In 2010, its operating income reached 103 million yuan with the net profit of 32.3411 million yuan.

 

Baotou Dongbao Biotech Co., Ltd. principally engages in the research, development, production and sale of gelatin series products and certain collagen protein. In 2010, its operating income reached 192 million yuan with the net profit of 21.6245 million yuan.

 

Jiangsu Feiliks International Logistics Inc. principally engages in designing and providing solution plans for integrated supply chain management. In 2010, its operating income reached 1.078 billion yuan with the net profit of 95.3426 million yuan.

 

 

 
Shenzhen Stock Exchange